logo en
  • Home
  • Manufacturing
    • Manufacturing
    • OEM Manufacturing
    • Quality Control
  • About the Factory
    • About the Factory
    • Our History
    • Management
    • Certificates
    • Partners
    • Licenses
    • Achievements
    • Special Evaluation of Labour Conditions
    • Videos
  • News
  • Products
  • Contacts
    • Contacts
    • Quality Claims
  • 简体中文(中国)
  • Russian (Russia)
  • You are here:  
  • Home /
  • News

News

Triazavirin, the Ural Wonder Drug, Enters the Russian Market

Details
Published: 22 September 2014

Already this season, the Ural Triazavirin will fight against flu and cold. The antiviral drug produced in Novouralsk will soon appear in Russian pharmacies. The Federal Ministry of Health issued a permission to produce the drug.

Read more ...

Triazavirin, a Drug for Influenza Developed by Ural Scientists, Enters the Production Stage

Details
Published: 22 September 2014

"The Ministry of Health of the Russian Federation issued a permission to produce the Triazavirin antiviral drug developed in the Urals," said Oleg Chupakhin, Chief Researcher at the Institute of Organic Synthesis, the Ural Branch of the Russian Academy of Sciences, and head of the drug development team.

Read more ...

The First Common Drug of Bayer and Medsintez Will Be the Avelox Antibiotic

Details
Published: 10 September 2013

YEKATERINBURG. Bayer, the German corporation, and Medsintez, the Novouralsk plant, have agreed on joint drug manufacturing.

Read more ...

Medsintez Launches Production of an Antibiotic for Tuberculosis

Details
Published: 06 September 2013
On September 9, Medsintez, the Novouralsk plant, will release its first lot of the Aveloks antibiotic. As Alexander Petrov (Jr.), Chairman of Medsintez's Board of Directors, told the EAN agency, the manufacturing of this new-generation drug is carried out according to the agreement signed with the plant's strategic partner, Bayer (Germany).

Read more ...

It Was Decided to Produce Insulin Syringe Pens at the Medsintez Plant

Details
Published: 20 August 2013

In Q4 2013, the Medsintez plant, for the first time in Russia, will begin to produce disposable insulin syringe pens for patients with diabetes mellitus. The price of a set of five pens will be approximately 600-700 roubles; a similar set from a foreign manufacturer costs 800 roubles. On prescription, residents of the Sverdlovsk region will be able to get them for free.

Read more ...

Page 10 of 12

  • Start
  • Prev
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • Next
  • End

Privacy Policy

Copyright © 2003-2023

+7 (34370) 2-50-61

+7 (34370) 2-54-95

Torgovaya 15, Novouralsk, Sverdlovsk region, Russia, 624130

Contacts